Dasatinib-induced Reversible Demyelinating Peripheral Neuropathy and Successful Conversion to Nilotinib in Chronic Myelogenous Leukemia-Reference-Cited by-同舟云学术

Dasatinib-induced Reversible Demyelinating Peripheral Neuropathy and Successful Conversion to Nilotinib in Chronic Myelogenous Leukemia

Published:2020-10-01 Issue:19 Volume:59 Page:2419-2421
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Inoue Hiroyasu¹²,Taji Hirofumi³,Yamada Kentaro¹,Iriyama Chisako³⁴,Saito Touko³,Kato Harumi³,Yanada Masamitsu³,Yamamoto Kazuhito³,Matsukawa Noriyuki²

Affiliation:

1. Department of Neurology, Nagoya City East Medical Center, Japan

2. Department of Neurology and Neuroscience, Nagoya City University Graduate School of Medical Sciences, Japan

3. Department of Hematology and Cell Therapy, Aichi Cancer Center Hospital, Japan

4. Department of Hematology and Oncology, Fujita Health University, Japan

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/internalmedicine/59/19/59_4824-20/_pdf

Reference8 articles.

1. 1. Kennedy JA, Hobbs G. Tyrosine kinase inhibitors in the treatment of chronic-phase CML: strategies for frontline decision-making. Curr Hematol Malig Rep 13: 202-211, 2018.

2. 2. Ishida T, Akagawa N, Miyata T. Dasatinib-associated reversible demyelinating peripheral polyneuropathy in a case of chronic myeloid leukemia. Int J Hematol 107: 373-377, 2018.

3. 3. Pasvolsky O, Leader A, Iakobishvili Z, et al. Tyrosine kinase inhibitor associated vascular toxicity in chronic myeloid leukemia. Cardio-Oncology 1: 5, 2015.

4. 4. Melfi S, Montt Guevara MM, Bonalume V, et al. Src and phospho-FAK kinases are activated by allopregnanolone promoting Schwann cell motility, morphology and myelination. J Neurochem 141: 165-178, 2017.

5. 5. Fraser CK, Lousberg EL, Kumar R, et al. Dasatinib inhibits the secretion of TNF-alpha following TLR stimulation in vitro and in vivo. Exp Hematol 37: 1435-1444, 2009.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cross-Domain Text Mining to Predict Adverse Events from Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia;Cancers;2022-09-26

2. Can rheumatologists stop causing demyelinating disease?;Multiple Sclerosis and Related Disorders;2021-08

3. Dasatinib;Reactions Weekly;2020-12